DiscoveryBioMed to Conduct Bioassay Testing for Lifeline | GenomeWeb

NEW YORK (GenomeWeb News) – DiscoveryBioMed today said that it has inked a service contract with Lifeline Cell Technology to conduct primary human cell bioassay testing for the subsidiary of International Stem Cell Corp.

The contract partners DBM's expertise in assay development with Lifeline's expertise in producing optimized human adult and stem cell products, said Lifeline CEO Jeffrey Janus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.